CRISPR Therapeutics AG
CRSP | NASDAQ
$50.45
-$0.97 (-1.89%)
Nov 2, 2026, 11:02 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 10.18M | 1.46M | 864K | 889K | 892K | 865K | 35M | 602K | 517K | 504K | 200M | n/a | 70M | 100M | 6K | 94K | 158K | 178K | 12.9M | 329K | 900.2M | 202K |
Cost of Revenue | 44.57M | 50.25M | 59.36M | 64.69M | 49.75M | 57.51M | n/a | 15.95M | 56.98M | 51.8M | 20M | 23.42M | 44.64M | 42.19M | 6.82M | 38.86M | 33.92M | 30.65M | 134.92M | 22.46M | 26.95M | 19.95M |
Gross Profit | -34.39M | -48.79M | -58.5M | -63.8M | -48.86M | -56.64M | 35M | -15.35M | -56.46M | -51.3M | 180M | -23.42M | 25.36M | 57.81M | -6.82M | -38.77M | -33.76M | -30.47M | -122.02M | -22.14M | 873.26M | -19.74M |
Operating Income | -114.8M | -130.25M | -154.76M | -132.06M | -133.07M | -148.42M | -64.59M | -110.13M | -151.26M | -140.59M | 69.58M | -132.41M | -95.22M | -64.49M | -131.54M | -182.39M | -183.26M | -175.97M | -145.7M | -128.85M | 762.62M | -114.54M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -90.19M | -122.09M | -130M | -105.82M | -207.26M | -134.89M | -36.61M | -85.07M | -125.12M | -115.87M | 89.58M | -111.74M | -76.82M | -51.75M | -120.05M | -175.12M | -179.72M | -175.61M | -139M | -127.75M | 763.37M | -112.59M |
Net Income | -91.15M | -122.93M | -130.61M | -106.44M | -208.55M | -136M | -37.31M | -85.94M | -126.41M | -116.59M | 89.35M | -112.15M | -77.74M | -53.07M | -110.58M | -174.55M | -185.83M | -179.22M | -141.25M | -127.15M | 759.23M | -113.16M |
Selling & General & Admin | 15.45M | 17.18M | 18.4M | 16.93M | 18.92M | 19.3M | 18.12M | 17.42M | 19.48M | 17.95M | 16.48M | 18.29M | 19.03M | 22.36M | 21.17M | 27M | 26.27M | 28.02M | 23.68M | 23.71M | 28.81M | 24.52M |
Research & Development | 64.95M | 68.57M | 77.87M | 58.9M | 65.29M | 72.48M | 82.16M | 77.36M | 75.32M | 71.34M | 95.14M | 90.7M | 101.56M | 99.94M | 103.56M | 116.62M | 123.22M | 118.25M | 103.1M | 83.5M | 82.33M | 70.62M |
Other Expenses | n/a | -4.3M | n/a | -7.58M | n/a | n/a | -691K | n/a | n/a | n/a | -1.21M | n/a | n/a | n/a | n/a | n/a | n/a | -762K | -103.1M | -495K | -499K | -337K |
Operating Expenses | 80.41M | 81.46M | 96.26M | 68.26M | 84.21M | 91.78M | 99.59M | 94.78M | 94.8M | 89.29M | 110.42M | 108.99M | 120.59M | 122.3M | 124.72M | 143.62M | 149.5M | 145.5M | 23.68M | 106.71M | 110.64M | 94.8M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 124.98M | 131.71M | 155.63M | 132.95M | 133.96M | 149.29M | 99.59M | 110.73M | 151.78M | 141.09M | 130.42M | 132.41M | 165.22M | 164.49M | 131.55M | 182.48M | 183.42M | 176.15M | 158.6M | 129.18M | 137.58M | 114.75M |
Income Tax Expense | 960K | 839K | 614K | 619K | 1.29M | 1.11M | 700K | 876K | 1.29M | 724K | 233K | 412K | 923K | 1.32M | -9.48M | -575K | 6.12M | 3.61M | 2.25M | -595K | 4.14M | 575K |
Shares Outstanding (Basic) | 96.51M | 96.05M | 89.93M | 91.31M | 87.07M | 85.94M | 85.46M | 85.24M | 84.92M | 81.79M | 79.69M | 79.41M | 79.09M | 78.68M | 78.34M | 77.92M | 77.43M | 77.1M | 76.65M | 76.14M | 75.83M | 74.94M |
Shares Outstanding (Diluted) | 96.51M | 96.05M | 89.93M | 91.31M | 87.07M | 85.94M | 85.46M | 85.24M | 84.92M | 81.79M | 81.32M | 79.41M | 79.09M | 78.68M | 78.34M | 78.02M | 77.51M | 77.1M | 76.65M | 76.29M | 80.45M | 75.01M |
EPS (Basic) | -0.94 | -1.28 | -1.37 | -1.17 | -2.40 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | 1.12 | -1.41 | -0.98 | -0.67 | -1.41 | -2.24 | -2.40 | -2.32 | -1.84 | -1.67 | 10.01 | -1.51 |
EPS (Diluted) | -0.94 | -1.28 | -1.37 | -1.17 | -2.40 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | 1.10 | -1.41 | -0.98 | -0.67 | -1.41 | -2.24 | -2.40 | -2.32 | -1.84 | -1.67 | 9.44 | -1.51 |
EBITDA | -110.5M | -117.77M | -124.34M | -101.39M | -202.66M | -130.15M | -31.77M | -80.33M | -120.28M | -111.03M | 94.48M | -106.82M | -71.86M | -46.69M | -114.21M | -170.11M | -172.45M | -169.57M | -132.73M | -122.42M | 767.02M | -111.83M |
EBIT | -114.8M | -122.09M | -130M | -105.82M | -207.26M | -134.89M | -36.61M | -85.07M | -125.12M | -115.87M | 89.58M | -111.74M | -76.82M | -51.75M | -120.05M | -175.12M | -179.72M | -175.61M | -139M | -127.75M | 763.37M | -114.54M |
Depreciation & Amortization | 4.3M | 4.32M | 5.66M | 4.43M | 4.6M | 4.74M | 4.84M | 4.74M | 4.85M | 4.83M | 4.9M | 4.93M | 4.96M | 5.05M | 5.85M | 5.02M | 7.27M | 6.04M | 6.26M | 5.32M | 3.65M | 2.72M |
Add to Watchlist
Select watchlists to add or remove CRSP